Roberto Estrada, MD
Geriatric Psychiatry · New York, NYNPI 1063506822
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $8,495 with a category attached, or 70.6%. Johnson & Johnson accounts for 94.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $7,787 and has fallen 99.2% since, to $61 in 2025. Among geriatric psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $326.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$8K
- AbbVie$250
- Vanda Pharmaceuticals Inc.$90
- Takeda Pharmaceuticals U.S.A., Inc.$68
- Neuronetics, Inc.$55
- Neurocrine Biosciences, Inc.$28
What the payments were for
- Consulting fees$6,00071%
- Travel & lodging$1,36816%
- Food & beverage$1,11913%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $8,003 |
| AbbVie | 2 | $250 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $68 |
| Neuronetics, Inc. | 2 | $55 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,495 in reported general payments places this provider in the 95th percentile of 45 geriatric psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 28 | $307 |
| Zolpidem Tartrate | 28 | $291 |
| Clonazepam | 28 | $175 |
| Lithium Carbonate ErLithium Carbonate | 15 | $134 |
| Duloxetine Hcl | 12 | $86 |
| Bupropion Hcl | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in New York
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.